These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3123810)

  • 1. Acute B-lymphocytic leukemia with L1 morphology: a report of two pediatric cases.
    Finlay JL; Borcherding W
    Leukemia; 1988 Jan; 2(1):60-2. PubMed ID: 3123810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
    Leverger G; Bancillon A; Schaison G
    Pathol Biol (Paris); 1987 Jan; 35(1):87-90. PubMed ID: 3550617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation by chemotherapy of T-cell antigen expression in B-cell chronic lymphocytic leukemia.
    Perl A; Szigeti A; Gergely P; Feher J; Magyarosi E; Sellyei M
    N Engl J Med; 1986 Jan; 314(3):186-7. PubMed ID: 2417119
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report.
    Preis PP; Zielinski CC; Linkesch W; Bettelheim P; Radaskiewicz T; Pavelka M; Haas O; Aiginger P
    Wien Klin Wochenschr; 1988 May; 100(10):331-6. PubMed ID: 3261061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of 2 chemotherapy protocols (VPA and C-VPA) in acute adult lymphoblastic leukemia].
    Avilés Miranda A; Ambriz Fernández R; Díaz Maqueo JC; Mascaró Sacristán J; Sinco Angeles A; Pizzuto J
    Rev Invest Clin; 1983; 35(4):285-9. PubMed ID: 6369467
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolymphocytic leukemia--a case report.
    Lee CS; Wang CH; Chang MC; Huang CH; Tsan KW; Chu ML
    Taiwan Yi Xue Hui Za Zhi; 1986 Jun; 85(6):630-7. PubMed ID: 3463667
    [No Abstract]   [Full Text] [Related]  

  • 11. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute leukemias].
    Gross R; Gerecke D
    Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia.
    Keating MJ; Scouros M; Murphy S; Kantarjian H; Hester J; McCredie KB; Hersh EM; Freireich EJ
    Leukemia; 1988 Mar; 2(3):157-64. PubMed ID: 3347094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vincristine utilized simultaneously or 24 hours before cyclophosphamide in maintenance regimen of acute lymphoblastic leukemia of children: a report of Childrens Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1981; 3(3):227-31. PubMed ID: 6945059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained complete remission in Richter's syndrome.
    Heslop HE; Fitzgerald PH; Beard ME
    Cancer; 1987 Mar; 59(5):1036-9. PubMed ID: 3815263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
    Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
    Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.